A novel CNS-homing peptide for targeting neuroinflammatory lesions in experimental autoimmune encephalomyelitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel CNS-homing peptide for targeting neuroinflammatory lesions in experimental autoimmune encephalomyelitis

Published:2020-06 Issue: Volume:51 Page:101530
ISSN:0890-8508
Container-title:Molecular and Cellular Probes
language:en
Short-container-title:Molecular and Cellular Probes

Author:

Acharya Bodhraj,Meka Rakeshchandra R.,Venkatesha Shivaprasad H.,Lees Jason R.,Teesalu Tambet,Moudgil Kamal D.

Funder

National Institutes of Health

European Regional Development Fund

Estonian Research Council

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference45 articles.

1. Immunology of relapse and remission in multiple sclerosis;Steinman;Annu. Rev. Immunol.,2014

2. Further understanding of the immunopathology of multiple sclerosis: impact on future treatments;Bhise;Expert Rev. Clin. Immunol.,2016

3. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire;Kuchroo;Annu. Rev. Immunol.,2002

4. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis;Steinman;Ann. Neurol.,2006

5. Experimental autoimmune encephalomyelitis (EAE);Racke;Curr. Protoc. Neurosci.,2001

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders;Pharmaceutics;2023-12-31

2. Potential nanocarrier-mediated miRNA-based therapy approaches for multiple sclerosis;Drug Discovery Today;2022-11

3. Peptide-Drug Conjugates: A New Hope for Cancer Management;Molecules;2022-10-25

4. Peptide Shuttles for Blood–Brain Barrier Drug Delivery;Pharmaceutics;2022-09-05

5. Targeted Delivery Platforms for the Treatment of Multiple Sclerosis;Molecular Pharmaceutics;2022-05-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3